Proprotein convertase subtilisin/kexin type 9 (PCSK9) and clinical outcomes in patients with end-stage renal disease

Eur J Clin Invest. 2024 Jun 10:e14262. doi: 10.1111/eci.14262. Online ahead of print.
No abstract available

Publication types

  • Editorial